Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Blood-based Test for Multi-cancer Early Detection in Asymptomatic Screening Population（ProSight）: a Multi-centre Interventional Study

NCT06790355 is registered in ClinicalTrials.gov with Shanghai Weihe Medical Laboratory Co., Ltd. as lead sponsor.

NCT NCT06790355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06790355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Blood-based Test for Multi-cancer Early Detection in Asymptomatic Screening Population（ProSight）: a Multi-centre Interventional Study
Lead sponsor
Shanghai Weihe Medical Laboratory Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2025
Completion date
August 31, 2026
Enrollment
2,527 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, esophageal cancer, grastic cancer, liver cancer, lung cancer